Stay updated on Lebrikizumab with Topical Corticosteroid in Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Lebrikizumab with Topical Corticosteroid in Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lebrikizumab with Topical Corticosteroid in Atopic Dermatitis Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The record describes a completed Phase 3 trial of lebrikizumab with topical corticosteroids for moderate-to-severe atopic dermatitis, including its study methods, participant criteria, outcomes, and locations. It also provides results-related publication and study documents, along with individual participant data sharing information.
    Difference
    99%
    Check dated 2026-11-07T15:15:33.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The site footer now identifies the ClinicalTrials.gov release as v3.8.0 instead of v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-31T15:53:48.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces a transition-related update and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T18:53:17.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The footer now displays site revision v3.7.2 instead of v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-17T20:42:54.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The footer revision number changed from v3.7.0 to v3.7.1 while the page continued to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-10T20:52:47.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, showing an access-denied notice instead of the study record content and navigation. This indicates the study page is currently inaccessible.
    Difference
    20%
    Check dated 2026-09-19T22:26:15.000Z thumbnail image

Stay in the know with updates to Lebrikizumab with Topical Corticosteroid in Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lebrikizumab with Topical Corticosteroid in Atopic Dermatitis Clinical Trial page.